Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
electroCore, Inc. - Common Stock
(NQ:
ECOR
)
5.350
-0.100 (-1.83%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about electroCore, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
NFL-Funded Study: CBD Or Non-Invasive Vagal Nerve Stimulation - Which Is Better To Alleviate Concussion Symptoms
↗
July 06, 2023
electroCore, Inc.’s (NASDAQ: ECOR) gammaCore non-invasive vagus nerve stimulation (“nVNS”) has been selected to be a part of studies on effects of cannabinoids and alternative care on athlete pain...
Via
Benzinga
electroCore Earnings Perspective: Return On Capital Employed
↗
May 11, 2023
Via
Benzinga
electroCore: Q1 Earnings Insights
↗
May 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
March 24, 2023
Via
Benzinga
Electrocore Inc. (NASDAQ: ECOR) Near the Top of Equities by Percentage Gain on 3/24
March 24, 2023
Via
Investor Brand Network
electroCore's Truvaga Users Reported Improved Stress, Anxiety, Sleep, Energy and Mood in Recent Focus Group Study
March 21, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Earnings Perspective: Return On Capital Employed
↗
March 10, 2023
Via
Benzinga
A Preview Of electroCore's Earnings
↗
March 07, 2023
Via
Benzinga
electroCore Announces Reverse Stock Split
February 14, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury
March 23, 2023
Pre-clinical trial demonstrates the ability of nVNS to decrease the amount of brain injury, decrease anxiety and improve motor function post injury
From
electroCore, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
March 16, 2023
Via
Benzinga
electroCore Affirms No Direct Exposure to Silicon Valley Bank, Silvergate Bank, or Signature Bank
March 14, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Announces Poster to be Presented at the 2023 American Academy of Neurology Annual Scientific Meeting
March 13, 2023
Poster Highlights the Ability of Non-Invasive Vagus Nerve Stimulation (nVNS) to Accelerate Learning of a Second Language
From
electroCore, Inc.
Via
GlobeNewswire
electroCore to Participate at 35th Annual Roth Conference
March 09, 2023
From
electroCore, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 8, 2023
↗
March 08, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
Via
Benzinga
electroCore Regains Compliance with Nasdaq Listing Requirements
March 07, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore to Announce Fourth Quarter and Year Ended December 31, 2022 Financial Results on Wednesday, March 8
March 01, 2023
From
electroCore, Inc.
Via
GlobeNewswire
7 Stocks to Sell as Borrowing Costs Rise
↗
February 28, 2023
With new economic data boding poorly for risk-on investments, investors should strongly consider targeting stocks to sell.
Via
InvestorPlace
10 Short Squeeze Candidates: Getty Images, Genius Brands, Lannett And More
↗
February 27, 2023
Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...
Via
Benzinga
electroCore, Inc. Announces Exclusive Distribution Agreement with Byond Healthcare Pty Ltd, South Africa
February 21, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Expands Intellectual Patent Portfolio for nVNS Technology
February 16, 2023
From
electroCore, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
February 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
January 24, 2023
Via
Benzinga
electroCore Announces Expected Record 4Q 2022 Revenue of $2.5M; Provides Business Update
January 17, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Completes Sale of New Jersey Tax Benefits
February 15, 2023
From
electroCore, Inc.
Via
GlobeNewswire
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
January 17, 2023
Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
January 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
January 11, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 13, 2023
↗
January 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
December 30, 2022
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
